Developmental Outcomes of Preterm Infants With Neonatal Hypoglycemia

Rachel H Goode1, Mallikarjuna Rettiganti2, Jingyun Li2

  • 1Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee; rachel.goode@vanderbilt.edu.

Pediatrics
|December 13, 2016
PubMed

Insights

Neonatal hypoglycemia in preterm infants did not significantly impact cognitive or academic skills. While behavioral differences were noted at age 18, they were not clinically meaningful, suggesting no long-term neurodevelopmental issues.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Neuroscience

Background:

  • Neonatal hypoglycemia is linked to potential neurodevelopmental issues, but studies present conflicting evidence.
  • Previous research on the long-term effects of neonatal hypoglycemia on preterm infants remains inconclusive.
  • Understanding the neurodevelopmental outcomes is crucial for effective neonatal care strategies.

Purpose of the Study:

  • To compare cognitive, academic, and behavioral outcomes in preterm infants with and without neonatal hypoglycemia.
  • To investigate long-term effects up to 18 years of age.
  • To clarify the association between neonatal hypoglycemia and neurodevelopmental trajectories in preterm infants.

Main Methods:

  • Secondary analysis of the Infant Health and Development Program cohort.
  • Stratification of 745 preterm infants into four glucose level groups.
  • Standardized cognitive, academic, and behavioral assessments at 3, 8, and 18 years, adjusting for multiple covariates.

Main Results:

  • No significant differences in cognitive or academic skills were found between hypoglycemic and normoglycemic preterm infants.
  • Infants with more severe neonatal hypoglycemia reported fewer problem behaviors at age 18.
  • The observed behavioral difference at age 18 was statistically significant but not clinically meaningful.

Conclusions:

  • Neonatal hypoglycemia in preterm infants is not associated with significant long-term intellectual or academic deficits.
  • While a statistical behavioral difference was observed at age 18, it lacks clinical significance.
  • Findings align with previous studies indicating no major neurodevelopmental impairment from neonatal hypoglycemia in this population.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
972
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K